Please login to the form below

Not currently logged in
Email:
Password:

Internis appoints Sandoz's Paul Tredwell

He joins the UK bone disorder-focused start-up as chief operating officer

Internis Paul TredwellInternis has poached Sandoz's former head of biopharmaceuticals Paul Tredwell to serve as its chief operating officer.  

Tredwell joins the UK bone disorder-focused start-up after serving at Sandoz for four years, during which time he set up a new division in the UK and was directly responsible for managing the sales, marketing and medical functions.  

Prior to his time with the firm, which operates as Novartis' generics division, Tredwell spent eight years with Shire in senior sales and marketing positions. These included leading the UK specialist sales teams as well as its commercial and NHS teams.  

Paul began his career in the pharmaceutical industry with Galen 16 years ago where he served as area sales manager.  

In his new role Tredwell will be tasked with driving sales of Internis' calcium products FultiumD3 and Accrete D3, as well as a number of new products the firm plans to introduce early next year.  

He will report to Internis' joint CEO Alan Walker who said: "We are delighted to have Paul Tredwell join our team. Paul is a recognised global leader in his field.  

“His skills, knowledge and extensive experience in the industry, as well as his ability to deliver results, make him the ideal candidate to lead Internis into the next exciting phase of its development."

27th August 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics